
CRISPR, stemcell banking, and a football world cup
Medicine and Science from The BMJ
00:00
CRISPR Innovations in Sickle Cell Treatment
This chapter explores the revolutionary application of CRISPR technology in the NHS for treating sickle cell disease and beta thalassemia, highlighting the first approved CRISPR-based treatment, Cascade. It also discusses the complexities and decision-making involved in current therapies, including stem cell transplantation, while addressing misconceptions and the importance of community support for patient care.
Transcript
Play full episode